Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Flu season is underway. What are common symptoms to watch for? - 2Manual for 6 Hot Brilliant Beds
- 3Why this Tennessee special election has the 'whole world' watching
- 4The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- 5America's Confided in Fridge in 2024
- Figure out How to Adjust Your Handshake to Various Societies
- Fundamental Home Machines: An Easy to understand Determination Guide
- All that You Really want to Be familiar with Dental Inserts Facilities
- Scientists find evidence that an asteroid contains tryptophan
- The Most Moving TED Talks You Want to Watch
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Bird flu poses risk of pandemic worse than COVID, France's Institut Pasteur says
